Over the past year, we covered a wide range of ground—from clinicians working directly with patients to top scientists studying the underlying biology of aging. This episode is a chance to look back at some of the more interesting conversations we had on Longevity Roadmap in 2025.

Looking ahead, there's no sign that the pace is slowing. In longevity, it often feels like every year brings another set of breakthroughs, and 2026 is shaping up to be a big one. One of the most important trends to watch is the increasing role of artificial intelligence in medicine, particularly in pharmaceuticals. AI-driven, network-based drug repurposing efforts are starting to identify compounds that may influence aging biology and move more efficiently toward clinically relevant interventions. By the end of 2026, it's reasonable to expect early readouts or expanded trials that begin to meaningfully target the hallmarks of aging.

Before wrapping up this year, I just want to say thanks to everyone who's been listening this year. Your interest, your feedback, and your willingness to think critically about this space are what make the show worth doing.

See you in 2026!

-

Download Dr. Buck Joffrey's FREE ebook, Living Longer for Busy People: https://ru01tne2.pages.infusionsoft.net/?affiliate=0

Book a FREE longevity coaching consultation with Dr. Buck Joffrey: https://coaching.longevityroadmap.com